The mechanism underlying the association of carcinoembryonic antigen with EGFR mutations remains unclear, and molecular studies are needed to investigate the difference in proliferation and survival between tumours with exon 19 and exon 21 mutations. The gene discussed is EGFR; the disease is neoplasm.